Durbin calls for federal investigations into ‘interlocking directorates’ in life science industry
Illinois Senator Dick Durbin, D-Ill., this week called for federal regulators to investigate potentially anticompetitive practices in the life science industry that could affect healthcare costs.
To access this content, you must purchase 1 Year Health News Illinois Subscription or 1 Year Group Subscription - Up to 5 Users, or log in if you are a member.
